Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 3Phase NA 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Recurrence 4Leukemia 3Burkitt Lymphoma 3Neoplasms 2Lymphoma, T-Cell 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, T-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Lymphoid 1Leukemia, Biphenotypic, Acute 1

Interventions

Cytarabine 13Cyclophosphamide 11fludarabine 10Filgrastim 8fludarabine phosphate 7Methotrexate 7Vincristine 6Specimen Handling 5Dexamethasone 5Biopsy 5venetoclax 4revumenib 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Azacitidine 4Whole-Body Irradiation 3Prednisone 3Mycophenolic Acid 3Leucovorin 3Hydrocortisone 3Clofarabine 3selinexor 2merphos 2ixazomib 2blinatumomab 2aldesleukin 2X-Rays 2Vorinostat 2Topotecan 2Thiotepa 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Biphenotypic, Acute × pegaspargase × Clear all
NCT05521087 2025-06-22

A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias

Janssen Research & Development, LLC

Phase 1 Withdrawn
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡